Literature DB >> 23852670

Toxicities and costs of placing prophylactic and reactive percutaneous gastrostomy tubes in patients with locally advanced head and neck cancers treated with chemoradiotherapy.

Andrew M Baschnagel1, Siddhartha Yadav, Ovidiu Marina, Aaron Parzuchowski, Thomas B Lanni, Jillian N Warner, Jeanne S Parzuchowski, Renjitha T Ignatius, Jan Akervall, Peter Y Chen, Daniel J Krauss.   

Abstract

BACKGROUND: We compared dependence rates, complications, toxicities, and costs associated with prophylactic versus reactive percutaneous endoscopic gastrostomy (PEG) tube placement.
METHODS: One hundred ninety-three patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy were retrospectively reviewed.
RESULTS: The 1-year and 2-year actuarial PEG tube dependence rate of the entire cohort was 24% and 13%, respectively. There was no difference in the PEG tube dependence rates between those placed prophylactically versus reactively. Patients who received a PEG tube reactively had a significantly higher stricture rate (p = .03) and aspiration rate (p < .001) compared to the prophylactic group. There were significantly fewer hospitalizations in the prophylactic group compared to the reactive group (p = .003). When accounting for both PEG placement and hospitalizations, the prophylactic approach was found to be more cost effective.
CONCLUSION: PEG tubes placed prophylactically were associated with lower rates of strictures, aspirations, hospitalizations, and costs compared to those placed reactively.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  percutaneous endoscopic gastrostomy (PEG) tube; prophylactic PEG tube; reactive PEG tube

Mesh:

Year:  2013        PMID: 23852670     DOI: 10.1002/hed.23426

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  18 in total

1.  Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer.

Authors:  T E Brown; V Getliffe; M D Banks; B G M Hughes; C Y Lin; L M Kenny; J D Bauer
Journal:  Eur J Clin Nutr       Date:  2016-02-10       Impact factor: 4.016

2.  Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.

Authors:  Xin Zhang; Matthew E Falagas; Konstantinos Z Vardakas; Rui Wang; Rong Qin; Jin Wang; Youning Liu
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

3.  Prospective experience of percutaneous endoscopic gastrostomy tubes placed by otorhinolaryngologist-head and neck surgeons: safe and efficacious.

Authors:  Johanna Ruohoalho; Katri Aro; Antti A Mäkitie; Timo Atula; Aaro Haapaniemi; Harri Keski-Säntti; Leena Kylänpää; Annika Takala; Leif J Bäck
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-01       Impact factor: 2.503

4.  Associations between pre-, post-, and peri-operative variables and health resource use following surgery for head and neck cancer.

Authors:  Hoda Badr; Maximiliano Sobrero; Joshua Chen; Tamar Kotz; Eric Genden; Andrew G Sikora; Brett Miles
Journal:  Oral Oncol       Date:  2019-02-11       Impact factor: 5.337

5.  Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy.

Authors:  Belinda Vangelov; Robert I Smee
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-07-26       Impact factor: 2.503

Review 6.  The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.

Authors:  Ronald Maggiore; Zachary S Zumsteg; Karlynn BrintzenhofeSzoc; Kelly M Trevino; Ajeet Gajra; Beatriz Korc-Grodzicki; Joel B Epstein; Stewart M Bond; Ira Parker; Julie A Kish; Barbara A Murphy; Noam A VanderWalde
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-07-15       Impact factor: 7.038

7.  Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Sharon H Giordano; Adam S Garden; Katherine A Hutcheson; Stephen Y Lai; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2016-09-23       Impact factor: 6.860

8.  Patients' characteristics informing practice: improving individualized nursing care in the radiation oncology setting.

Authors:  Pauline M Rose
Journal:  Support Care Cancer       Date:  2018-05-04       Impact factor: 3.603

9.  Rendezvous endoscopic recanalization for complete esophageal obstruction.

Authors:  Stefano Fusco; Thomas Kratt; Cihan Gani; Dietmar Stueker; Daniel Zips; Nisar P Malek; Martin Goetz
Journal:  Surg Endosc       Date:  2018-03-30       Impact factor: 4.584

Review 10.  Percutaneous endoscopic gastrostomy: indications, technique, complications and management.

Authors:  Ata A Rahnemai-Azar; Amir A Rahnemaiazar; Rozhin Naghshizadian; Amparo Kurtz; Daniel T Farkas
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.